Prospective Study to Compare the Efficacy of E.G.Scan to Detect Barrett's Esophagus Compared With Standard Endoscopy
Sponsored by Mayo Clinic
About this trial
Last updated 8 years ago
Study ID
13-008214
Status
Completed
Type
Interventional
Phase
N/A
Placebo
No
Accepting
18+ Years
All
Trial Timing
Ended 9 years ago
What is this trial about?
The purpose of this study was to evaluate whether a disposable nasal endoscope called "E.G.
Scan II" will visualize the esophagus as well as the standard test, sedated endoscopy.
What are the participation requirements?
Inclusion Criteria
1. Adult participants aged 18 years or above who are scheduled for routine upper GI endoscopy for Barrett's Esophagus surveillance, varices surveillance and dyspepsia.
2. Able and willing to give informed consent.
Exclusion Criteria
1. Patients known to be intolerant to endoscopy.
2. Patients with frequent epistaxis.
3. Patients not clinically fit for endoscopy as judged by their care team.
4. Pregnant women.
5. Patients with allergy/sensitivity to Simethicone (Mylicon), Phenylephrine, Lidocaine nasal spray, Benzocaine spray (Topex)
6. Use of anticoagulants or antiplatelets.